@article{deseze:hal-04086889,
TITLE = {Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic},
AUTHOR = {de S{\`e}ze, J{\'e}r{\^o}me and Maillart, Elisabeth and Gueguen, Antoine and Laplaud, David A. A. and Michel, Laure and Thouvenot, Eric and Zephir, Helene and Zimmer, Luc and Biotti, Damien and Liblau, Roland},
URL = {https://hal.science/hal-04086889},
JOURNAL = {Frontiers in Immunology},
PUBLISHER = {Frontiers},
VOLUME = {14},
PAGES = {1004795},
YEAR = {2023},
DOI = {10.3389/fimmu.2023.1004795},
KEYWORDS = {multiple sclerosis ; rituximab ; ocrelizumab ; ofatumumab ; ublituximab ; anti-CD20},
PDF = {https://hal.science/hal-04086889/file/fimmu-14-1004795.pdf},
HAL_ID = {hal-04086889},
HAL_VERSION = {v1},
}